| pubmed-article:15598666 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0035078 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0206074 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0243161 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C1428449 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0237400 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C0035611 | lld:lifeskim |
| pubmed-article:15598666 | lifeskim:mentions | umls-concept:C2698651 | lld:lifeskim |
| pubmed-article:15598666 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15598666 | pubmed:dateCreated | 2005-1-27 | lld:pubmed |
| pubmed-article:15598666 | pubmed:abstractText | We wished to determine the optimal duration of follow-up for patients with acute renal failure (ARF) treated with continuous renal replacement therapy (CRRT) and tested the hypothesis that a 6 month follow-up would be the minimum to catch most of the mortalities. In addition, we evaluated the association between mortality and the RIFLE classification in the same patients. | lld:pubmed |
| pubmed-article:15598666 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15598666 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15598666 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15598666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15598666 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15598666 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15598666 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:EkbomAndersA | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:GranathFredri... | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:MartlingClaes... | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:BellMaxM | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:LiljestamEvaE | lld:pubmed |
| pubmed-article:15598666 | pubmed:author | pubmed-author:FryckstedtJes... | lld:pubmed |
| pubmed-article:15598666 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15598666 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:15598666 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15598666 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15598666 | pubmed:pagination | 354-60 | lld:pubmed |
| pubmed-article:15598666 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:meshHeading | pubmed-meshheading:15598666... | lld:pubmed |
| pubmed-article:15598666 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15598666 | pubmed:articleTitle | Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. | lld:pubmed |
| pubmed-article:15598666 | pubmed:affiliation | Department of Anaesthesiology and Intensive Care, Karolinska University Hospital, S-171 76 Stockholm, Sweden. max.bell@karolinska.se | lld:pubmed |
| pubmed-article:15598666 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15598666 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15598666 | lld:pubmed |
